L. Oreland

951 total citations
33 papers, 706 citations indexed

About

L. Oreland is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Clinical Psychology. According to data from OpenAlex, L. Oreland has authored 33 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 5 papers in Clinical Psychology. Recurrent topics in L. Oreland's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). L. Oreland is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). L. Oreland collaborates with scholars based in Sweden, Estonia and Japan. L. Oreland's co-authors include Jaanus Harro, Arvid Carlsson, L. Svennerholm, Rolf Adolfsson, Aquilonius Sm, Bengt Winblad, Jonas Ekblom, S. S. Jossan, Yumiko Arai and Anders Stenström and has published in prestigious journals such as Biological Psychiatry, Neuroscience and Biochemical Pharmacology.

In The Last Decade

L. Oreland

32 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Oreland Sweden	15	327	178	131	116	101	33	706
D.L. Murphy United States	13	290 0.9×	124 0.7×	105 0.8×	129 1.1×	62 0.6×	26	691
L. Demisch Germany	19	200 0.6×	126 0.7×	133 1.0×	82 0.7×	65 0.6×	55	920
Mike F. Hawkins United States	17	371 1.1×	168 0.9×	59 0.5×	44 0.4×	157 1.6×	35	727
Åsa Wiberg Sweden	5	219 0.7×	95 0.5×	76 0.6×	58 0.5×	114 1.1×	6	511
Beáta Búzás United States	20	649 2.0×	505 2.8×	113 0.9×	56 0.5×	185 1.8×	25	1.1k
P Jenner United Kingdom	16	521 1.6×	258 1.4×	37 0.3×	204 1.8×	78 0.8×	35	889
Hans‐Willi Clement Germany	13	201 0.6×	166 0.9×	93 0.7×	39 0.3×	67 0.7×	31	671
Mohab Alexander United States	14	661 2.0×	224 1.3×	228 1.7×	232 2.0×	95 0.9×	32	1.3k
Deborah K. Hyslop United States	12	515 1.6×	324 1.8×	42 0.3×	101 0.9×	61 0.6×	19	900
Vincent Beliveau Austria	16	324 1.0×	107 0.6×	175 1.3×	121 1.0×	49 0.5×	39	828

Countries citing papers authored by L. Oreland

Since Specialization

Citations

This map shows the geographic impact of L. Oreland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Oreland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Oreland more than expected).

Fields of papers citing papers by L. Oreland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Oreland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Oreland. The network helps show where L. Oreland may publish in the future.

Co-authorship network of co-authors of L. Oreland

This figure shows the co-authorship network connecting the top 25 collaborators of L. Oreland. A scholar is included among the top collaborators of L. Oreland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Oreland. L. Oreland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Comasco, Erika, et al.. (2017). COMT genotype and non-recovery after a whiplash injury in a Northern European population. BMC Musculoskeletal Disorders. 18(1). 507–507. 7 indexed citations

Oreland, L., et al.. (2015). Monoamine Oxidase Activity and Localisation in the Brain and the Activity in Relation to Psychiatric Disorders1. PubMed. 19. 246–254. 2 indexed citations

Garpenstrand, Håkan, Britt af Klinteberg, Elena L. Grigorenko, et al.. (2002). Low platelet monoamine oxidase activity in Swedish imprisoned criminal offenders : European Neuropsychopharmacology. European Neuropsychopharmacology. 12(2). 135–140. 6 indexed citations

Fetissov, Sergueı̈ O., J. Hallman, L. Oreland, et al.. (2002). Autoantibodies against alfa-MSH, ACTH and LHRH in anorexia and bulimia nervosa patients : Proceedings of the National Academy of Sciences USA. 99(26). 1 indexed citations

Harro, Jaanus, et al.. (2000). Lesioning of Locus coeruleus Projections by DSP-4 Neurotoxin Treatment: Effect on Amphetamine-Induced Hyperlocomotion and Dopamine D2 Receptor Binding in Rats. Pharmacology & Toxicology. 86(5). 197–202. 35 indexed citations

Ågren, Hans, et al.. (1998). Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour. European Neuropsychopharmacology. 8(2). 153–157. 37 indexed citations

Oreland, L., et al.. (1998). Transmethylation Reactions and Autoradiographic Distribution of Vitamin B12: Effects of Clioquinol Treatment in Mice. The Japanese Journal of Pharmacology. 78(1). 55–61. 8 indexed citations

Stålenheim, E. Gunilla, Lars von Knorring, & L. Oreland. (1997). Platelet monoamine oxidase activity as a biological marker in a Swedish forensic psychiatric population. Psychiatry Research. 69(2-3). 79–87. 34 indexed citations

Sakurai, Eiichi, et al.. (1995). Effects of the histamine H3 agonist (R)-alpha-methylhistamine and the antagonist thioperamide in vitro on monoamine oxidase activity in the rat brain.. PubMed. 17 Suppl C. 46–50. 1 indexed citations

10.

Prince, Jonathan A., et al.. (1994). Mitochondrial enzyme deficiencies in Downs Syndrome. Journal of Neural Transmission. 8. 171. 10 indexed citations

11.

Sherif, Fathi M., Jaanus Harro, Abdalla Elhwuegi, & L. Oreland. (1994). Anxiolytic-like effect of the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA) on rat exploratory activity. Pharmacology Biochemistry and Behavior. 49(4). 801–805. 35 indexed citations

12.

Ekblom, Jonas, S. S. Jossan, Per‐Göran Gillberg, L. Oreland, & Sten‐Magnus Aquilonius. (1992). Monoamine oxidase-B in motor cortex: Changes in amyotrophic lateral sclerosis. Neuroscience. 49(4). 763–769. 12 indexed citations

13.

Inoue, Osamu, et al.. (1990). Effect of reserpine on the brain uptake of carbon 11 methamphetamine and itsN-propagyl derivative, deprenyl. European Journal of Nuclear Medicine and Molecular Imaging. 17(3-4). 121–126. 7 indexed citations

14.

Jossan, S. S., Roland d'Argy, Per‐Göran Gillberg, et al.. (1989). Localization of monoamine oxidase B in human brain by autoradiographical use of11C-labelled L-deprenyl. Journal of Neural Transmission. 77(1). 55–64. 26 indexed citations

15.

Klinteberg, Britt af, Daisy Schalling, Gunnar Edman, L. Oreland, & Marie Åsberg. (1987). Personality Correlates of Platelet Monoamine Oxidase (MAO) Activity in Female and Male Subjects. Neuropsychobiology. 18(2). 89–96. 57 indexed citations

16.

Sedvall, G., et al.. (1984). Genetic studies of CSF monoamine metabolites.. PubMed. 39. 79–85. 4 indexed citations

17.

Carlsson, Arvid, Rolf Adolfsson, Aquilonius Sm, et al.. (1980). Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.. PubMed. 23. 295–304. 120 indexed citations

18.

Oreland, L.. (1980). MONOAMINE OXIDASE ACTIVITY AND AFFECTIVE ILLNESS. Acta Psychiatrica Scandinavica. 61(S280). 41–47. 56 indexed citations

19.

Adolfsson, Rolf, et al.. (1977). Monoamine oxidase activity in gamma-irradiated rat brains.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 153(6). 431–2. 1 indexed citations

20.

Oreland, L.. (1972). Some properties of pig liver mitochondrial monoamine oxidase.. PubMed. 5. 37–43. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact